ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,028Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 457

$1.52M Total Retail Price of All Prescriptions

Rank: 18 out of 457

541 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

2% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 25,509 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 960 872 1 1
SIMVASTATIN 827 738 2 2
LISINOPRIL 779 705 3 3
METOPROLOL TARTRATE 698 633 4 7
LEVOTHYROXINE SODIUM 648 622 5 5
IBUPROFEN 633 571 6 14
AMLODIPINE BESYLATE 630 584 7 4
METFORMIN HCL 566 489 8 6
FUROSEMIDE 503 461 9 10
MUPIROCIN 499 447 10 91
NAMENDA 390 375 11 32
DONEPEZIL HCL 385 378 12 22
SSD 382 356 10 13 158
POTASSIUM CHLORIDE 381 349 14 28
RANITIDINE HCL 366 352 15 17
CARVEDILOL 354 333 16 20
NEXIUM 339 305 17 12
HYDROCHLOROTHIAZIDE 338 312 18 8
CITALOPRAM HBR 331 324 19 45
LACTULOSE 330 296 20 78
SILVER SULFADIAZINE 320 318 10 21 127
ATENOLOL 310 263 22 11
MEGESTROL ACETATE 295 283 R 23 94
ZOLPIDEM TARTRATE 283 261 24 13
CRESTOR 266 240 25 9
QUETIAPINE FUMARATE 261 259 26 109
TRAZODONE HCL 256 244 27 104
CLOPIDOGREL 254 249 28 19
CLOTRIMAZOLE-BETAMETHASONE 237 229 29 60
AMMONIUM LACTATE 236 231 30 82
DICLOFENAC SODIUM 235 231 31 49
TAMSULOSIN HCL 235 213 31 36
LIDODERM 233 213 33 31
SURE COMFORT 233 227 33 103
DIOVAN 230 230 35 30
PLAVIX 227 218 36 24
DIGOXIN 225 225 37 69
LOSARTAN POTASSIUM 223 211 38 18
ZAFIRLUKAST 222 205 10 39 213
LANTUS 219 204 40 56
CLONIDINE HCL 213 199 41 52
FAMOTIDINE 196 162 42 62
KETOCONAZOLE 193 167 43 92
CARBIDOPA-LEVODOPA 192 180 44 128
MECLIZINE HCL 188 185 45 55
NOVOLIN 70-30 178 172 46 113
NOVOLIN R 175 159 47 147
CLOBETASOL PROPIONATE 172 131 48 125
GABAPENTIN 169 149 49 15
ESCITALOPRAM OXALATE 168 139 50 61
SINGULAIR 164 150 51 43
SEROQUEL XR 149 142 52 168
LANSOPRAZOLE 146 145 53 74
METOPROLOL SUCCINATE 139 108 54 21
ENALAPRIL MALEATE 137 126 55 35
DIOVAN HCT 133 113 56 51
HYDRALAZINE HCL 130 103 57 148
ADVAIR DISKUS 130 117 57 27
SANTYL 126 123 59 307
SYMBICORT 124 116 60 106
SEROQUEL 124 121 60 182
CLOTRIMAZOLE 122 106 62 207
INSULIN SYRINGE 122 98 62 79
AZITHROMYCIN 115 102 64 44
ALENDRONATE SODIUM 114 101 65 16
VOLTAREN 114 111 65 34
PAROXETINE HCL 113 113 67 68
LEVETIRACETAM 108 62 68 160
ISOSORBIDE MONONITRATE ER 105 105 69 84
METOCLOPRAMIDE HCL 103 99 70 116
GLIPIZIDE 102 99 71 42
FLUTICASONE PROPIONATE 101 91 72 40
MONTELUKAST SODIUM 101 89 72 86
PHENYTOIN SODIUM EXTENDED 99 30 74 171
MIRTAZAPINE 99 91 74 100
RISPERIDONE 98 98 76 102
PANTOPRAZOLE SODIUM 98 85 76 59
NIFEDIPINE ER 96 82 78 89
DEXILANT 96 89 78 118
RESTASIS 93 82 80 175
DICYCLOMINE HCL 92 87 81 115
EXELON 92 92 81 98
WARFARIN SODIUM 91 67 83 38
BUSPIRONE HCL 91 91 83 170
LOVAZA 91 72 83 50
SERTRALINE HCL 91 63 83 57
COMBIVENT 86 66 87 133
ALBUTEROL SULFATE 80 68 88 151
TRICOR 80 60 88 83
AMITIZA 78 66 90 302
LEXAPRO 77 72 91 138
CIPROFLOXACIN HCL 77 74 91 71
GLYBURIDE-METFORMIN HCL 76 70 R 93 70
THEOPHYLLINE ANHYDROUS 76 73 93 244
GLYBURIDE 76 76 R 93 64
ATORVASTATIN CALCIUM 76 68 93 33
TRAMADOL HCL 74 64 97 26
NITROGLYCERIN PATCH 74 74 97 157
AMLODIPINE BESYLATE-BENAZEPRIL 73 64 99 72
OXYBUTYNIN CHLORIDE ER 71 53 100 195
CHOLESTYRAMINE 71 65 100 327
PENTOXIFYLLINE 70 68 102 67
LYRICA 70 44 102 77
DOXAZOSIN MESYLATE 68 66 104 73
ABILIFY 67 48 105 146
LOPERAMIDE 64 52 106 264
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 61 107 153
CYMBALTA 61 61 108 97
SUCRALFATE 61 60 108 163
FENOFIBRATE 61 50 108 46
DOXYCYCLINE HYCLATE 61 56 108 241
TOBRAMYCIN-DEXAMETHASONE 60 60 112 431
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 49 112 37
AVODART 59 59 114 110
ACTOS 58 58 115 105
CELEBREX 56 41 116 53
BENZTROPINE MESYLATE 55 37 R 117 171
CYPROHEPTADINE HCL 53 49 R 118 258
BACLOFEN 53 40 118 141
LUMIGAN 52 52 120 259
NITROSTAT 51 51 121 167
PRAMIPEXOLE DIHYDROCHLORIDE 51 51 121 266
GALANTAMINE HBR 50 50 123 194
BUMETANIDE 50 49 123 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.